Maryanne B. O'donnell
Randwick, NSW 2031, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Weight loss and gut microbial changes associated with semaglutide among people living with schizophrenia receiving clozapine or olanzapine: An open-label 24-week semaglutide intervention and 76-week trial.
Journal: Schizophrenia research
Published: January 29, 2026
Toll-Like Receptor mRNA Levels in Schizophrenia: Association With Complement Factors and Cingulate Gyrus Cortical Thinning.
Journal: Schizophrenia bulletin
Published: December 16, 2023
Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: A randomized control trial.
Journal: Brain, behavior, and immunity
Published: April 24, 2023
The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses.
Journal: Pathogens (Basel, Switzerland)
Published: August 30, 2022
Underuse of recommended treatments among people living with treatment-resistant psychosis.
Journal: Frontiers in psychiatry
Published: July 06, 2022
Peripheral complement is increased in schizophrenia and inversely related to cortical thickness.
Journal: Brain, behavior, and immunity
Published: July 30, 2021
Peripheral NF-κB dysregulation in people with schizophrenia drives inflammation: putative anti-inflammatory functions of NF-κB kinases.
Journal: Translational psychiatry
Published: July 19, 2021
Cortisol-dehydroepiandrosterone ratios are inversely associated with hippocampal and prefrontal brain volume in schizophrenia.
Journal: Psychoneuroendocrinology
Published: April 23, 2020
Reducing barriers to the diagnosis of obstructive sleep apnoea in patients with severe mental illness.
Journal: The Australian and New Zealand journal of psychiatry
Published: January 18, 2020
Altered levels of immune cell adhesion molecules are associated with memory impairment in schizophrenia and healthy controls.
Journal: Brain, behavior, and immunity
Published: November 12, 2019
Transcriptional changes in the stress pathway are related to symptoms in schizophrenia and to mood in schizoaffective disorder.
Journal: Schizophrenia research
Published: November 13, 2018
C-Reactive Protein: Higher During Acute Psychotic Episodes and Related to Cortical Thickness in Schizophrenia and Healthy Controls.
Journal: Frontiers in immunology
Published: June 24, 2018
Last Updated: 09/26/2026